Multicenter phase I dose escalation and expansion study of pyrotinib in combination with camrelizumab and chemotherapy as first-line treatment for HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma
| Autor: | Li, Sheng, Bao, Jun, Li, Xiaoyou, Yang, Quanliang, Xu, Junying, Chen, Surong, Feng, Ge, Gao, Chao, Feng, Lin, Lu, Bin, Miao, Min, Ni, Xinchu, Wang, Guofang, Yang, Lei, Zhu, Liangjun |
|---|---|
| Zdroj: | In eClinicalMedicine December 2023 66 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|